Exator Tablet 5/80/20 Milligrams
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HanKuk Hyutex Pharmaceuticals Co., Ltd.
MFDS item code 202105301 · Approved 2021.07.12
Treatment of hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease (e.g., myocardial infarction and stroke)
This medication is used for patients with essential hypertension who struggle to achieve blood pressure control with monotherapy, as a combination of amlodipine and valsartan. The inclusion of atorvastatin also reduces the risk of myocardial infarction, stroke, vascular interventions, and angina in patients at high risk for cardiovascular diseases, and helps treat dyslipidemia. Atorvastatin is particularly effective for patients with hypercholesterolemia, mixed dyslipidemia, and genetic lipid disorders, and can be used when dietary therapy alone is insufficient or where alternative treatments are not feasible. This medication is used to effectively reduce the risk of cardiovascular diseases by managing both blood pressure and blood lipid levels.
Take 1 tablet once daily with water. If possible, it is recommended that you take it at the same time every day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination Before administering the amlodipine/valsartan combination, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, a direct switch to the amlodipine/valsartan combination may be considered if blood pressure is not controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medicine may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. - Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. - Elderly patients: The efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
This medication may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. If there are any symptoms related to muscles or if there is a significant increase in creatine kinase levels, this medication should be discontinued. Caution is especially necessary when severe myopathy is suspected, as it may lead to renal function deterioration. This medication should not be administered to patients with certain diseases or conditions. For example, patients with allergies to the drug's components, pregnant or nursing women, patients with severe liver or kidney function impairment, and those who may experience problems when taking it alongside specific drugs should not use this medication. Patients with low sodium or fluid levels in the body should correct their condition prior to taking this medication, and if symptoms of low blood pressure occur during use, immediate action such as lying down and administering saline if necessary is required. Patients with high potassium levels should frequently monitor their potassium levels while taking this medication, as hyperkalemia may worsen. Patients with renal vascular issues, those who have received kidney transplants, those with a history of angioedema, and patients after heart failure or myocardial infarction must take this medication with caution and be closely monitored. While taking this medication, regular tests for liver and kidney function should be completed, and symptoms such as muscle pain, weakness, fatigue, or fever should be reported to a physician immediately. Caution may be needed while driving or operating machinery as dizziness or fatigue may occur. There may be interactions with other drugs, so if you are taking any other medications, you must inform your doctor or pharmacist, especially when using certain antibiotics, antifungals, immunosuppressants, or some antiviral medications. Pregnant or nursing women should not use this medication, and fertile women should utilize appropriate contraception methods while taking this medication. This medication is not recommended for children, so consultation with a specialist is required before administering it to pediatric patients.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Avoid excessively hot or cold locations, and it is best to keep it in a cool place away from direct sunlight.
Light orange oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HanKuk Hyutex Pharmaceuticals Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.